Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 04:03
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
The 20.02% gross margin accelerated to, up from 8.71%.
The company's revenue growth yoy .8% accelerated to, up from 31.4%. Marginal operating leverage .71% accelerated to, up from 5.93%. The decline in daily volume . The close price .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 20.02 % | 8.71 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 8.71 % | 5.93 | ▲ |
| REVENUE_GROWTH_YOY | 34.8 % | 31.4 | ▲ |
| PRICE_CHANGE_PERCENT | -3.742 % | — | - |
| DAILY_VOLUME | 1,000 shares | 6,571 | ▼ |
| CLOSE_PRICE | 463 INR | 481 | ▼ |
Cite this
Source: Samhati evidence synthesis for CLN (2026-10-21). Observation: The 20.02% gross margin accelerated to, up from 8.71%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/cln
Filing step-changes